Olympus Corporation

2026/08/21 Updated
Market Cap: $14.6B (¥2.3T)
Stock Price: $13.76 (¥2,187)
Exchange Rate: 1 USD = ¥158.98

【Olympus】Notice of Full-Year Earnings Forecast and Actual Results Difference|May 2026

Olympus's consolidated net sales for the fiscal year ending March 2026 exceeded the previous forecast, reaching 10,106.76 billion yen, with profits also increasing. Contributions came from effective promotional activities in the North American endoscopy business and gains from asset sales.

Importance:
Page Updated: May 12, 2026
IR Disclosure Date: May 12, 2026

Key Figures

  • Net Sales: 10,106.76 billion yen (+1.3%)
  • Operating Income: 97.12 billion yen (+11.6%)
  • Net Income Attributable to Owners of the Parent: 68.17 billion yen (+15.5%)

AI要約

Financial Overview

Olympus's consolidated net sales for the fiscal year ending March 2026 reached 10,106.76 billion yen, surpassing the previous forecast. Profits also exceeded expectations, with operating income at 97.12 billion yen and net income attributable to owners of the parent at 68.17 billion yen. The North American endoscope solution sales promotions and gains from asset sales contributed to this result.

Future Outlook and Impact

The positive performance this period was driven by the effectiveness of promotional activities and revenue increases from asset sales. Moving forward, the company aims to secure stable profits through continued expansion of the endoscope business and ongoing asset sales. Despite potential fluctuations due to exchange rates and market trends, steady financial performance is expected.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Olympus Corporation

Company overview · Stock price · Financial data · All IR

View company page →